Crossmark

Postoperative Carbohydrate Antigen 19-9 Level as a Good Indicator of Ineffective Response to the Currently Recommended S-1 Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma: A Single-Center, Retrospective Study

Crossref DOI link: https://doi.org/10.1245/s10434-023-14440-0

Published Online: 2023-10-18

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ariake, Kyohei

Okada, Takaho

Tsuchiya, Haruyuki

Kuboki, Daiki

Maemura, Kimiya

Okada, Yuki

Ichikawa, Hidetaka

Tachibana, Tomoyoshi

Akazawa, Naoya

Abe, Tomoya

Kakita, Tetsuya

Oikawa, Masaya

Tsuchiya, Takashi
License Information

Text and Data Mining valid from 2023-10-18

Version of Record valid from 2023-10-18
More Information

Article History

Received: 13 June 2023

Accepted: 27 September 2023

First Online: 18 October 2023

Disclosure

: The authors have no conflicts of interest to disclose in relation to this study.

Document is current

Any future updates will be listed below